HUNTINGTON BEACH, California and AMSTERDAM, Netherlands, September 18 /PRNewswire/ --

Agendia, a world leader in molecular cancer diagnostics, today announced that its signature breast cancer tumor recurrence test, MammaPrint(R), has been included in the updated 2008 guidelines of The Dutch Institute for Healthcare Improvement CBO. The CBO guidelines, which cover all areas of healthcare and have an important role to play in the improvement of the quality of patient treatment and care, were drafted in collaboration with the Dutch Association of Comprehensive Cancer Centers (ACCC) and the Dutch National Breast Cancer Consultation Group (NABON).

TORONTO, Canada, September 18 /PRNewswire/ -- Trillium Therapeutics Inc., a privately-held biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders, announced today that it has secured CDN$12 million in new financing from its existing investors, VenGrowth Private Equity Partners, BDC Capital and Canadian Medical Discoveries Fund (CMDF).

SINGAPORE, September 18 /PRNewswire/ --

- First Truly Global CDN Supports Gaming Initiatives in APAC

MAIDENHEAD, England, September 18 /PRNewswire/ --

- New Study Results Further Support That Enbrel Effectively Clears Skin, Reduces the Prevalence of Depression and Anxiety and Improves Patients' Quality of Life

LONDON, September 18 /PRNewswire/ --

- 'Marketisation of the Vulnerable' to be Raised at Labour Party Conference

Changes in legal aid services, which help people keep 'a roof over their head', tackle unemployment and advise on crippling debts are to be raised at the Labour Party conference, by Unite.

Unite, the country's largest trade union, believes that legal assistance is being reduced, as a result of the introduction of fixed fees per case, for groups such as:

- those with literacy difficulties, - mental health problems, - disabilities, - asylum seekers and refugees

Under the Legal Services Commission's (LSC) new scheme, people with complex cases are finding it harder to get a legal aid solicitor, or an advice agency to take them on.

PRINCETON, New Jersey, September 18 /PRNewswire/ --

- Laureate To Add Single-Use Bioreactor (S.U.B.) To Its Portfolio Of Assets -

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it is increasing its existing manufacturing capacity by adding two Single-Use Bioreactors (S.U.B.). Acquisition of a 250L and a 1000L S.U.B. will give Laureate greater flexibility in meeting the varying needs of its clients.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )